Who We Are

Clinixir was established in June 2020 with initial investments from BualuangVenture (BV), and 8 academic institutions.
A government grant under PMU-C was awarded in 2020 to establish infrastructure to maintain and enhance Thailand’s competitiveness in Clinical Research.

Clinixir operates as a private company with a governance board consisting of academic representatives and BV delegates.
By establishing a full-service Contract Research Organization (CRO) Thailand’s clinical research capabilities to support local innovations are supported; ultimately attracting global clinical research activities


To provide one-stop clinical research services that meet global standards for Medical Product development.

Thai patients have early access to medical products.

Support Thailand’s innovation and reduce national medical expenditures.

Develop Thai performance as part of global workforce and increasing Thailand GDP.